Welcome to the Industrial Automation website!

NameDescriptionContent
HONG  KANG
E-mail  
Password  
  
Forgot password?
  Register
当前位置:

A hundred years of magnificent history, there are other worlds to change the world

来源: | 作者:佚名 | 发布时间 :2024-01-31 | 919 次浏览: | 🔊 Click to read aloud ❚❚ | Share:

First, chaos is not divided, seams for survival

Like most national industry and commerce, China's pharmaceutical industry also sprouted in the late Qing Dynasty and the early Republic of China, which was a great era of absurd humiliation but surging.

Since the Opium War opened China's doors, foreign capital and goods have poured in.

British businessmen Lao De Ji, Watsons pharmacy everywhere, almost swept the capital cities of China.

Every pharmacy earned a pot full of pot, Japan "Ren Dan" can almost be used to describe the flood.

The power of the "Treaty of Shimonoseki" allowed foreign companies to obtain the privilege of opening factories in China, and foreign companies took the opportunity to expand the original Western pharmacy into a pharmaceutical factory.

Founded in 1900, "Shide's Pharmaceutical Factory" was the first foreign pharmaceutical factory since the end of the Qing Dynasty.

Profitable, naturally there is a story of unwilling people.

In response to the call of the government to "master Yi and grow skills to control Yi", many national capitalists invested in the construction of factories.

In 1912, Huang Chujiu founded Shanghai's first national capital Western medicine factory Longhu Company in Hankou Road, specializing in the production and marketing of "Longhu human Dan".

The advertisement of "Travel should not be unprepared, home should not be unprepared, the king of first aid, the treasure of the world" is overwhelming, which can be said to be the first advertising of pharmaceutical companies.

The copycat version of "Rendan" once became a symbol of domestic products, and Japanese businessmen were even angry to Sue Western medicine factory Longhu Company for trademark infringement.

In this age of humiliation, feeding the family is the only goal in the struggle to survive.

Foreign painkillers, landing in China will become pain relief powder, analgesic Dan, rejuvenation prescription... ; The same kind of oil is more varied, universal oil, Ruyi oil, free oil, cross oil, hundred grass oil, heart oil, driving oil...

A hall can not, another hall to continue to sell, all change, as long as you can make money on the line.

At this time, drug manufacturers and pharmaceutical factories, as long as they are alive, they are more important than anything else.

Talk of ambition, to help the people, seems a little pale and weak.

Two, the danger of survival, moral speech

When the nation is in danger of survival, some people lower their heads, some people seek peace, some people stay away from right and wrong, of course, some people sacrifice their lives to go to the country, and the medical industry is no exception.

The rise of the May Fourth Movement woke up the sleeping lion.

"Boycott Japanese goods, promote domestic goods" resounding in the sky, Qin Runqing, then president of Shanghai Money Industry Association, put forward the important proposition that "business should also love the country".

On the one hand, the national pharmaceutical industry has sensed an opportunity for commercial development, and on the other hand, it is encouraged by patriotic propositions.

Xiang Songmao of Wuzhou Pharmacy Co., LTD., shouted angrily: "Selling foreign products, but picking up the rest of the soup, you must make new drugs to compete with it."

In 1921, Wuzhou Guben Soap Pharmaceutical Factory was formally established. By 1931, Wuzhou Pharmacy had 17 branches, 55 associated enterprises, and more than 100 kinds of products, worth nearly 10 million yuan, becoming the largest pharmaceutical enterprise in China at that time.

Like the five continents, the national pharmaceutical companies at this time are carrying the ideal of "saving the country by industry", and they are not afraid of power and make great strides.

After 1920, pharmaceutical factories in Shanghai, Guangzhou and other big cities mushroomed, and a large number of national enterprises with market competitiveness emerged, such as Shanghai Wuzhou, Sino-French, Xinya Pharmaceutical Factory, Guangzhou He Jigong, Huang Baoshan Pharmaceutical Factory, Tianjin Zhongxi, Weidimin Pharmaceutical Factory, etc.

In 1924, there were only 93 ethnic medicine factories founded by Chinese people, and by 1936, there were more than 300 in major provincial capitals.

Shot the first bird, Xiang Songmao's life is like a bright fireworks, frozen in the moment of full bloom. He was unfortunately captured by the Japanese army, however, he faced the enemy chief, righteously, and died in the country.

Item old to life to write "flat living should be a few want to keep healthy, the festival is a health commission; The family must live within its means, and take the great meaning as a precious treasure ", which encourages entrepreneurs to move on and on.

At the time of national salvation, ethnic medicine companies are like bronze peas that cannot be steamed, cooked, hammered, fried or banged, and only need a drop of rain to break the ground.

Three, between mountains and Yu, ups and downs

Never an industry is always smooth sailing, only through ups and downs, but standing, showing the hero, the backbone of the pharmaceutical industry is not in vain.

In 1937, the Japanese invaders set foot on the land of China, and the war began to smoke.

The Japanese army's three-light policy of "killing all, grabbing all and burning all" almost swept the major national industries and commerce.

Drugs were in greatest demand during the war. The importance of the pharmaceutical industry is self-evident, and the eyes of the Japanese army will naturally not let go of the national pharmaceutical industry in its embryonic stage.

In the early days of the war of Resistance, the Japanese artillery almost blew up the entire national pharmaceutical industry.

The wildfire burns endlessly, the spring breeze blows again.

The soaring price of drugs has naturally attracted speculative capital from all walks of life in order to hoard for profit.

With the help of capital, the pharmaceutical industry quickly recovered. Some well-equipped pharmaceutical factories began to research and produce chemical apis, such as glucose for injection and various sulfonamide antibiotics.

On August 15, 1945, Japan announced its unconditional surrender, and the eight years of Anti-Japanese War finally brought peace.

The heroic singing of "Returning Home in Triumph" resounded throughout the land of China.

All walks of life are gearing up to do a great job and relieve eight years of oppression.

However, for the national pharmaceutical industry, the bigger test is still to come.

The Pacific War came to an abrupt end with the rapid defeat of Japan. The military medicine stockpiled by the US-led Allies had no use for it and had to be piled up in ports in the Far East.

The exquisite self-interest of capitalism is aimed at China, which is still in a state of ruin.

Surplus military drugs flooded into the Chinese pharmaceutical market, and domestic bureaucratic capital also took the opportunity to fan the fire, advocating the import of Western drugs, at one point 80% of the drugs on the market were imported.

In today's terms, this is naked dumping.

At the time, however, China was unable to anti-dumping.

Unable to compete, the national pharmaceutical companies are rapidly declining and closing down one after another. More than 70% of national pharmaceutical companies have been removed from the list, leaving less than 200 pharmaceutical factories, and survivors can only be at a semi-standstill.

The Chinese pharmaceutical industry, which survived the war of resistance, was hit hard by Allied dumping.

At this time, the medical community realized that living to death can be more tenacious, even if the road ahead is full of difficulties and dangers, have the confidence to get out of the trough, and have the courage to move forward fearlessly, is the real fighter.

4. Self-reliance and self-sufficiency

In 1949, the People's Republic of China was founded, the mountains and rivers were rebuilt, and the national industry beat the waters and the waves stopped the flying boats, but it was blocked by Western imperialism.

The greatest "achievement" of the Western imperialist policy of blockade and embargo is to force the new China to establish a complete, systematic, comprehensive and independent industrial system.

This is one of the important roots of the formation of the new China's independent, self-reliant and self-sufficient industrial system and economic development strategy, and the re-formal start of China's pharmaceutical industry is in this context.

After the devastation of the war and the dumping of the Allies, the lack of medicine is the true portrayal of the new China when it was founded.

Raw material shortage, backward technology, outdated equipment, weak foundation...

At this time of new China, medicine is more expensive than gold, and a medicine is difficult to find, folk spread: gold has a price and a drug is priceless.

It is with this wisdom and confidence that the Chinese pharmaceutical industry has launched a national plan.

In 1950, the National Pharmaceutical industry professional conference established the policy: "The development of raw materials, preparations as a supplement", the research and development of antibiotics, sulfonamides and other epidemic drugs as a focus.

"Self-reliance, hard work" has always been the glorious tradition of the Communist Party, with the transformation of enemy and counterfeit pharmaceutical factories, dilapidated factories, only three years of economic recovery period will produce more than 90 major chemical raw materials, the annual output of 99 tons.

We are familiar with the story: Shanghai Pharmaceutical factory auto repair plant trial produced the first batch of crystalline penicillin, the cradle of the chemical pharmaceutical industry, Northeast pharmaceutical produced a batch of rodenticides, insecticides and drinking water disinfectants such as 66, Qingshuilong... Set up one monument after another for later pharmaceutical people.

In 1953, with the beginning of the "First Five-Year Plan", the focus of pharmaceutical industry construction was shifted to antibiotics, chemical synthetic special drugs and related chemical intermediates.

Once the largest antibiotic production factory in Asia - North China Pharmaceutical Factory was completed and put into operation, completely ending the history of penicillin and streptomycin in China's dependence on imports.

Penicillin, which used to cost more than gold, has dropped to just a few cents a piece.

The large-scale production of antibiotics has made many diseases disappear in China, such as pneumonia, meningitis, tuberculosis and so on.

As a result, many Chinese believed that diseases could be fundamentally cured, and life expectancy in China increased dramatically, the "curse" of early death in middle age in backward regions was gone forever.

In 1964, China set up a trial pharmaceutical industry trust to implement unified management, unified accounting and unified distribution of people, goods and materials, and the profits of the national pharmaceutical industry were uniformly handed over to the state Treasury by the trust.

In addition, with the promulgation of regulations such as the "Measures for the Administration of Pharmaceutical Equipment Manufacturing" and the "Regulations on the Administration of Patent Medicines", the quality of drugs has been guaranteed, and the output, output value and profits of drugs have increased exponentially.

Under the state planning system, the main varieties of antibiotics, sulfonamides and endemic drugs have been basically self-sufficient, and the backward situation of dependence on imports of raw materials has been got rid of.

Under the unified leadership of the Party Central Committee, the regional medicine, health and other departments, adhere to the principle of facing the countryside and facing the people, and the past valuable drugs have developed into commonly used drugs for urban and rural medical treatment.

In 1967, the total output value of China's pharmaceutical industry had reached 7.2 billion yuan, and the output of six types of chemicals exceeded 13,000 tons.

Striving for the liberation and happiness of the people has always been the original aspiration of the CPC, and placing the people's health in a strategic position of development has always been the mission of the CPC.

The pharmaceutical industry from decline to prosperity, from small workshops to a complete system, from the lack of medicine to meet the needs of basic drugs, which is a great practice of China's pharmaceutical industry gradually towards independence.

The spring story, Western learning to the east

"Spring thunder ah woke up inside and outside the Great Wall, spring light ah warm through the two sides of the Great river", the story of spring from the South China Sea border small quickly resounded across the land of China. "Emancipate the mind, seek truth from facts", the chief designer through thousands of years of wisdom and calm, for the Chinese giant ship to take the helm. China has reached a crossroads, and so has its pharmaceutical industry.

Ten years of unrest, let the pharmaceutical industry on the right track once again encountered Waterloo, disorderly pharmaceutical factories, disorderly production of drugs, shoddy manufacturing... Chaos reigned and development stalled.

There may be troubles and opportunities in the growth of any industry, and the long wait for ten years has finally ushered in a turning point.

In 1978, the Third Plenary Session of the 11th CPC Central Committee sounded the clarion call for reform and opening up.

The establishment of the State Administration of Medicine has realized the unified management of medicine in the true sense.

The release of various relevant policies has made great changes in the face of medical production in China.

How to deal with the relationship between "reform" and "opening up", how to deal with the relationship between "introduction" and "going out", has become the first important proposition of the State Administration of Medicine.

These two groups of relationships, to grasp both hands, both hands must be hard.

At that time, Lin Dong, director of the Office of the Foreign Affairs Bureau of the State Medical Administration, set his sights on Japan, which has deep roots with China and a desire for win-win cooperation.

The signing of the China-Japan Friendship Treaty and the promulgation of the Law on Sino-Foreign Joint Ventures have greatly accelerated the process of negotiation and cooperation.

In 1980, Lin Dong and Otsuka Akuhiko signed three documents on behalf of China and Japan respectively, the Contract for Joint Venture Operation of China Otsuka Pharmaceutical Co., LTD., the Technical Cooperation Contract and the Articles of Association of China Otsuka Pharmaceutical Co., LTD.

China Pharmaceutical Industry Corporation and Otsuka Pharmaceutical Co., Ltd. of Japan invested in the establishment of a joint venture - Otsuka Pharmaceutical Co., LTD., the first pharmaceutical joint venture in New China was born.

A single flower does not make a spring. Under the guidance of emancipating the mind, China's pharmaceutical industry ushered in the story of spring, the grass is growing and the nightingals are flying.

In 1981, China Pharmaceutical Foreign Trade Corporation was established, establishing an international exchange platform;

In 1982, the United States Squibb Company, China Pharmaceutical Foreign Trade Corporation and Shanghai Pharmaceutical Industry Company jointly established Sino-US Shanghai Squibb Pharmaceutical Co., LTD., which became the first Sino-US joint venture pharmaceutical company and passed the FDA certification.

Through the introduction, digestion and absorption, the national pharmaceutical industry has made great progress in terms of technology, varieties, dosage forms, quality and scale, coupled with the acceleration of the GMP promotion process, the popularization of new business concepts, the industrial scale has basically doubled every 5 years, and the whole industry has taken on a new look.

Chinese medicine needs the world, and world medicine also needs China.

In 1983, the "Vitamin C two-step fermentation production process" independently developed by the Institute of Microbiology of the Chinese Academy of Sciences and Beijing Pharmaceutical Factory was transferred to Roche of Switzerland at a price of 5.5 million US dollars, achieving a breakthrough of "zero" technology export.

The first epoch-making product that became a global blockbuster was artemisinin.

In October 1981, at the International Artemisinin Conference held in Beijing sponsored by the World Health Organization, Tu Youyou made a report on the Chemical Research of artemisinin as the chief spokesperson, which was highly praised, saying that "the discovery of artemisinin not only adds a new antimalarial drug, but also has a more important significance in discovering the unique chemical structure of this new compound." It will point the way to the synthetic design of new drugs."

In 1992, in response to the shortcomings of artemisinin such as high cost and difficulty in curing malaria, Professor Tu Youyou's team invented dihydroartemisinin, an "upgraded version" with 10 times the anti-malaria effect of the former.

This drug is praised by the international medical community as the "killer" of drug-resistant malaria, and it is a drug that China has independent intellectual property rights and truly goes to the world.

In October 2015, the Karolinska Institute of Medicine of Sweden announced in Stockholm that Tu Youyou, a Chinese female pharmacologist and chief researcher of the Institute of Traditional Chinese Medicine of the China Academy of Traditional Chinese Medicine, won the 2015 Nobel Prize in Physiology or Medicine.

The spring breeze of reform is invigorated, and the open door inspires innovation. By 1995, the national production of chemical raw materials had reached 330,000 tons, and bulk chemicals such as antibiotics and vitamins had become the main force in the international market supply, and China's modern pharmaceutical industry had finally taken a place in the world.


  • ABB Processor 958481321200 350211080320 CPU Module
  • ABB Processor 958481321220 350211080320 CPU Module
  • ABB Processor 958481320100 350211080090 CPU Module
  • Pro-Face PL5901-T42-24V HMI Touch Panel
  • PROFIBUS PB3-VME-1-E V1.2.2 Interface Card
  • PROMESS 850040060P Force Displacement Monitor
  • PROSOFT AN-X2-AB-DHRIO DH+ and Remote I/O Gateway
  • PROSOFT RLX2-IFH24E Industrial Wireless Radio Module
  • PROSOFT 5202-DFNT-MCM4 DF1 to EtherNet/IP Gateway
  • PROSOFT PLX35-NB2 EtherNet/IP to Modbus TCP Gateway
  • ProSoft 5201-MNET-MCM-WEB Modbus TCP/Serial Gateway
  • ProSoft 5304-MBP-PDPMV1 Modbus Plus to PROFIBUS DP Master
  • ProSoft 5302-MBP-MCM4 Modbus Plus to Modbus Master/Slave
  • ProSoft 5301-MBP-DH485 Modbus Plus to DH485 Gateway
  • ProSoft 6104-WA-PDPM Wireless PROFIBUS DP Master
  • ProSoft MVI56-LTQ ControlLogix Limitorque Master
  • Prosoft 5304-MBP-PDPM PROFIBUS Master Module
  • Prosoft 1452-25M Relay Output Module
  • Prosoft MVI56-MNETR Modbus TCP/IP Module
  • Prosoft MVI69L-MBS Modbus Serial Module
  • Prosoft PLX32-EIP-SIE Ethernet Gateway
  • Prosoft MVI56-PDPS PROFIBUS DP Slave Module
  • Prosoft PMF1327205 Gateway Module
  • Prosoft PMF1216D61 FOUNDATION Fieldbus Module
  • PROSOFT MVI56-GSC Generic Serial Communication Module
  • PROSOFT 5601-RIO-MCM Remote I/O Communication Module
  • PROSOFT 1454-9F Communication Interface Module
  • PROTECH SYSTEMS PBI-6SA Industrial Single Board Computer
  • PRSTECH DMP10.24-20 DIN-Rail Power Supply
  • PRT PSA300R-81 Industrial Power Supply Module
  • PULS SLA8.100 AS-Interface Power Supply
  • QSI QTERM-K65 Industrial Operator Interface
  • R-2528Z R-2528Z Industrial Specialized Component
  • Radisys SBC486DX66 Single Board Computer
  • Radisys EPC-5 with EXM-13 Embedded System
  • Radisys EPC-16 Embedded Computer
  • Ramix PMC676TX PMC Ethernet Adapter
  • Ramix PMC008A PMC-to-VME Adapter
  • Ramix PMC237C-008EMI PMC Carrier
  • Ramix PMC661J PMC Carrier Board
  • Renata CR2450N Lithium Battery
  • Renault Circuit CU-8593-IND.A Control Module
  • Reotron 567LH-DP24 Voltage Regulator
  • RIFA IC693PWR321U GE Fanuc Series 90-30 Power Supply
  • RKC REX-B871NN-CS1B Intelligent Controller
  • RKC B871-RCU Digital Temperature Control Unit
  • ROBICON 469718 Variable Frequency Drive Control Board
  • IAI ROBO CYLINDER RC-S5-M-50-M Electric Actuator
  • Robo Cylinder RCA-T Electric Actuator
  • Rockwell 0-60066 Relay Output Module
  • Rockwell TC-303-02-4M0 Power Cable
  • Rockwell TC-302-02-4M0 Encoder Cable
  • Rockwell TC-205-02-8M5 Cable Assembly
  • Rockwell SA3100 AC Drive
  • Rockwell Automation T9110 Processor Module
  • Rockwell Automation 56AMXN I/O Module
  • ROD-L M100DC-5-10 High Voltage Dielectric Withstand Tester
  • ROE ELKO RAUH ⅡA 2200MFD 40V Electrolytic Capacitor
  • ROEMHEKD D35321 Hydraulic Clamping and Power Component
  • Rofin Laser HG-24 Industrial Laser Marking and Processing System
  • Ropex RES-402/400VAC Temperature Controller
  • Rorze RD-023MS Stepping Motor Driver
  • Rosemount 3D39861G01 Circuit Board Assembly
  • Rosemount SCL-C-003-M2 Interface Module
  • Rosemount 3051TG2A2B21AB4M5 Pressure Transmitter
  • ROSS 400C79 Pneumatic Valve Coil
  • RPSTECH DMP10.24 SIC DIN Rail Power Supply
  • RS NX-X16D Digital Output Module
  • RVSI SCANSTAR240 Barcode Scanner
  • SABO MPB.533.00 PLM500 PLC Module
  • SAC IOP313 Analog Input Module
  • SAC IOP310 Industrial I/O Module
  • GE P111-6052 Micro Controller Module
  • Samsung D0C-16C Digital I/O Control Module
  • SAMWONTECH TLC990ME-83 Multi-Channel PID Controller
  • SanDisk SDP3B-10 Industrial Flash Storage
  • SAC IOP351 Advanced Processor
  • SAC IOP331 Input/Output Processor Technical
  • Saftronics EZ6 40 Soft Starter Manual
  • Sagemcom 252720938AB Signal Processor
  • Sagemcom 252721117AC Interface Module
  • Sagemcom 252721013AF Controller
  • SAIA PCD2.W610 Analog Output Module
  • SAIA PCD3.R60X Flash Memory Storage Module
  • SAT RM3141-01-02 CM3141-01-02 System
  • SAT CM3142-01-03 CX3147-04 Overview
  • SAT CM3141-02-03 CX3149-05 Technical Manual
  • Sauter AVM234SF132 Valve Actuator Specs
  • SBS PFSK165 3BSE027778R1 Technical Specs
  • SBS VIPC616 91611524 VME Carrier Board
  • SBS PMC-HS-SERIAL Interface Module
  • Schenck FNT-L001 Network Terminal Guide
  • Schenck VEG20400 Weighing Electronics Specs
  • Schiele DL42N-22 Multi-Function Relay
  • Schiele DL22N-22 Monitoring Relay Specs
  • Schleicher SSY52 Safety Control Unit Manual
  • Schleicher UST21 Control Module
  • SanDisk 336A4940EZP1 Industrial SSD
  • Sankyo PC10021 Industrial Control Module
  • SANMOTION PB3A003P200 Servo Drive
  • Sanyo P30B04010PCKST AC Servo Motor
  • Sanyo STNM-DR-250B Industrial Drive Module
  • Sanyo STNM-DR-160B Mixed I/O Module
  • Sanyo PMDAA1SFC20R Servo Amplifier
  • Sartorius MDB-5E Precision Weighing Module
  • SBS VIPC616 VME-IP Carrier Board
  • SBS 82002070 High-Performance Control Module
  • SBS P2-100BT-ER Industrial Ethernet Module
  • SBS 82002077 Industrial Control Module
  • SCANLAB INTELLISCANDE14-405NM UV Laser Scan Head
  • SCANLAB INTELLISCANDE14-1064NM IR Laser Scan Head
  • SCANLAB INTELLISCANDE III14-532NM Laser Scan Head
  • SCHAFFNER FN3416-110-35 EMI Power Line Filter
  • SCHROFF MPS015 Series
  • SCHROFF MPS015 13100205 Power Supply
  • SCHROFF 3BSC690076R5 Module Review
  • SCHUMACHER ATCS-15 1464-0320 Review
  • SCHUMACHER MDIA-162 System Analysis
  • SCHUMACHER ATCS-15 Technical Guide
  • Schumacher 1442-0010H Industrial Battery Charger Module
  • Seagate ST3630A 3.5 Inch IDE Hard Drive
  • SEC PB5F-DYL Latching Relay Output Module
  • SEC PB5F-DYI Isolated High-Density Output Module
  • SEC PB5F-DY High-Density Digital Output Module
  • SEC PB5-DY 5-Channel Digital Output Module
  • SEC PB4-DYI Isolated Digital Output Module
  • SEC PB4-DY 4-Channel Digital Output Module
  • SECO B161S-E176 Control Card